• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Up 0.36%

    Trevena, Inc. (TRVN)

    -NasdaqGS
    5.30 Up 0.33(6.64%) 4:00PM EST
    |After Hours : 5.40 Up 0.10 (1.89%) 7:26PM EST
    Add to Portfolio
    Prev Close:4.97
    Open:5.10
    Bid:N/A
    Ask:24.01 x 17200
    1y Target Est:15.33
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:4.90 - 5.30
    52wk Range:3.80 - 9.95
    Volume:188,877
    Avg Vol (3m):144,264
    Market Cap:199.42M
    P/E (ttm):N/A
    EPS (ttm):-2.48
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for TRVN

    Comparison

    Symbol% ChgMkt Cap
    TRVNUp 6.64%199.42M
    CYTK 0.00%179.01M
    NVSUp 0.04%228.83B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):N/A
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-2.17
    Quarterly EPS Est (Dec-14) :-0.56
    Mean Recommendation*:1.7
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Trevena, Inc., a clinical stage biopharmaceutical company, discovers, develops, and intends to commercialize therapeutics for G protein coupled receptors. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback